Altimmune rises as buyout rumors follow R&D updates
Shares of Altimmune ( NASDAQ: ALT) traded sharply higher on Friday after the obesity drug developer generated buyout rumors ...
Altimmune’s (ALT) Market Perform Rating Reaffirmed at William Blair
William Blair reaffirmed their market perform rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report ...
European Medical Journal23h
Managing MASLD in Patients with Type 2 Diabetes
Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
HC Wainwright Has Pessimistic Outlook of ALGS Q1 Earnings
Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E.
Health on MSN6h
What To Expect From a FibroScan (Transient Elastography)
Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...